IL6 and breast carcinoma: The upregulation of the expression of proinflammatory cytokines [including TNF-α, IL-8, and interleukin-6 (IL-6)] and neutrophil survival have been reported to promote protumorigenic (N2) phenotype TANs in a breast cancer model.